Sep. 10 at 3:37 PM
$GALT
Interesting ……..
89bio attended the H.C. Wainwright conference appearance for September 8, 2025—just 10 days before Roche announced its acquisition on September 18. Conference record
SEC filings later revealed that 89bio and Roche had signed a 25-day exclusivity agreement on August 29, with proposed terms of
$14.50 per share upfront plus up to
$6 in contingent payments. Due diligence and negotiations over the merger documents were underway around the conference date. The definitive acquisition agreement was signed on September 17. SEC filing
Is history repeating!!!!
